Our Thoughts

Congratulations to Exact Imaging!


January 10th, 2017
Posted by

Congratulations to our client, Exact Imaging, for securing CND $21.5 million in financing to support the commercialization of its new disruptive ExactVu™ Micro-Ultrasound for prostate imaging and biopsy. Founded in 2013, the company’s goal is to disrupt the market and enable new levels of clinical imaging. With its new technology, urologists can now visualize areas of interest in the prostate and specifically target biopsies at those areas in addition to performing systematic biopsy protocols.

Read the rest of this entry »


Posted in biomedical research

2016 Year in Review


December 14th, 2016
Posted by

popper-annual-report-blog

It’s been quite a year for healthcare. In 2016, we witnessed patients access care through the palms of their hands, providers increasingly use data to drive decision-making, and we reached an inflection point for genomics as consumers, providers, and other stakeholders increasingly became aware of the field and its role in healthcare.

Read the rest of this entry »


Posted in biomedical research

Immunic Acquires 4SC’s Immunology Portfolio


November 14th, 2016
Posted by

regulatory_t_cells

After announcing the the closure of Series A funding with $19.6 million, Immunic recently acquired 4SC’s immunology portfolio. The acquisition adds two promising drug development programs to the biotech startup’s portfolio to treat immune and autoimmune diseases.

Founded in 2016 by Manfred Groppel and Popper’s senior advisor, Dr. Andreas Muehler, Immunic develops pharmaceuticals in the immunology space, in particular for autoimmune diseases or diseases that have an important immunology component in their pathogenesis.

We are excited about the potential impact of this acquisition which will start with a clinical study involving Crohn’s patients, and are continuing to track these and other developments at the intersection of biotechnology and immunology.

Read more about the acquisition.

 


Posted in biomedical research

Solving the Value Equation for Molecular Diagnostics


November 1st, 2016
Posted by

Idea Bulb Concept Drawing on Blackboard

In this special blog post, we share insights from national genomics reimbursement expert and former Medicare medical director, Dr. Bruce Quinn, on how to create and capture value in precision medicine.


As medicine continues to become more personalized, the biggest challenges to the precision medicine market aren’t scientific, they’re economic. These barriers are drawing more attention – from payers such as United Healthcare urging MDx reimbursement reform to healthcare systems such as Cleveland Clinic which presented several views of payment redesign at their 2016 Medical Innovation Summit. A recent GenomeWeb article by Monica Heger echoed this sentiment, citing the need for partnerships and novel regulatory structures to address challenges with diagnostic test development, reimbursement, and regulation.

Read the rest of this entry »


Posted in biomedical research

The Power of Genomics: The Road Less Traveled


October 10th, 2016
Posted by

Landscape with fork rural roads in forest

You could say that we’re in an era of ambitious genomic projects and healthcare is getting smarter faster than ever. From Illumina’s plans to become the “Google of genetic testing” to pharmaceutical companies’ adoption of DNA sequencing as the foundation of their business strategy, an arms race is underway to sequence, commercialize, and democratize genetic information.

Read the rest of this entry »


Posted in biomedical research

Conference Roundup: The Year for Diagnostics


September 7th, 2016
Posted by

The global molecular diagnostics market continues to grow and change at a rapid pace. Danaher’s recent announcement that they are building their diagnostics portfolio by acquiring Cepheid is just the latest example. Several trends are driving this growth including changes in clinical practice, innovations in technology, and a changing regulatory environment aimed at promoting point-of-care diagnostics.

Read the rest of this entry »


Posted in biomedical research

Making Healthcare Smarter: Quest Diagnostics


September 2nd, 2016
Posted by

iStock_74720979_sm

Industry leader Quest Diagnostics recently announced the release of CogniSense, its digital cognitive testing technology. This important new tool is designed to help physicians and accountable care organizations (ACO) improve the detection and monitoring of patients with dementia and Alzheimer’s disease, as well as other types of cognitive dysfunction.

Read the rest of this entry »


Posted in biomedical research

Making the Case for Smarter Healthcare


July 27th, 2016
Posted by

In a conceptual model of healthcare originally proposed by William Kissick, MD, there are three competing issues that enter into any dialogue on how to improve our healthcare system. The three sides of this Iron Triangle of Healthcare are quality, access, and cost. Constant trade-offs have to be made since the classic approach to health economics dictates that you can improve any one – or perhaps even two – of these elements, but only at the expense of the third.

The model states that you can advance the quality of a product or service, making it better for a higher price. Or you can create a lower cost alternative for as many people as possible, but that inevitably means that quality suffers. Each choice has its own set of sociopolitical implications that must be weighed against each other.  Read the rest of this entry »


Posted in biomedical research, Our Views

Medical innovation takes a village… or an ecosystem


June 10th, 2016
Posted by

gray

In 1996, Hillary Clinton used the opening of the African proverb “it takes a village to raise a child” as the title and central theme of a best-selling book that helped launched a political career in her own right. Today, a full 20 years later – roughly the amount of time it takes to fully raise a baby into an independent adult – she is still very actively pursuing her goals.

While this column takes no position on Ms. Clinton as a candidate, both the proverb and the time horizon in question are good parallels for the development and adoption of important new medical advances. Read the rest of this entry »


Posted in Our Views

Immuno-Oncology – Good Today, Great Tomorrow


May 2nd, 2016
Posted by

Researchers in the field of immuno-oncology have achieved remarkable success over the past five years. The ability to boost the immune system to attack cancer using a variety of biotechnology-derived approaches has led to the successful treatment of thousands of patients with advanced melanoma, lung cancer, and various types of leukemia. The success of these approaches has extended the lives of many patients, a significant number of whom have seemingly been cured. All of this has created a great deal of excitement and optimism among patients, researchers, and physicians after many years of frustration, false starts, and failed trials.

Read the rest of this entry »


Posted in biomedical research

« Older Entries